Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sagent Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19

americanpharmaceuticalreviewNovember 24, 2020

Tag: Sagent , COVID-19 , CAMELOT , Camostat Mesilate

PharmaSources Customer Service